CA2050275A1 - Production de pvz du ibdv dans une forme hautement immunogene - Google Patents

Production de pvz du ibdv dans une forme hautement immunogene

Info

Publication number
CA2050275A1
CA2050275A1 CA 2050275 CA2050275A CA2050275A1 CA 2050275 A1 CA2050275 A1 CA 2050275A1 CA 2050275 CA2050275 CA 2050275 CA 2050275 A CA2050275 A CA 2050275A CA 2050275 A1 CA2050275 A1 CA 2050275A1
Authority
CA
Canada
Prior art keywords
ibdv
pyelc5
strain
clone
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2050275
Other languages
English (en)
Inventor
Ahmed A. Azad
Ian G. Macreadie
Neil M. Mckern
Paul R. Vaughan
Mittur N. Jagadish
Kevin J. Fahey
Antony J. Chapman
Hans-Georg Heine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2050275A1 publication Critical patent/CA2050275A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA 2050275 1989-05-30 1990-05-29 Production de pvz du ibdv dans une forme hautement immunogene Abandoned CA2050275A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ4469 1989-05-30
AUPJ446989 1989-05-30

Publications (1)

Publication Number Publication Date
CA2050275A1 true CA2050275A1 (fr) 1990-12-01

Family

ID=3773949

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2050275 Abandoned CA2050275A1 (fr) 1989-05-30 1990-05-29 Production de pvz du ibdv dans une forme hautement immunogene

Country Status (1)

Country Link
CA (1) CA2050275A1 (fr)

Similar Documents

Publication Publication Date Title
EP0755259B1 (fr) CLONES D'ADNc CHIMERES DU VIRUS DE LA BURSITE INFECTIEUSE, PRODUITS D'EXPRESSION ET VACCINS A BASE DESDITS CLONES
Macreadie et al. Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast
CA1337181C (fr) Vaccin recombinant a base de gb et de gd contre l'herpes
CA2084413A1 (fr) Compositions et methodes pour la prevention et le diagnostic de la maladie de lyme
NO313917B1 (no) Antigen-presenterende kapsid med fusert MS2-kappeprotein
JPS60155128A (ja) 膜結合性タンパク質を含有するワクチン類
US5614409A (en) Production of IBDV VP2 in highly immunogenic form
AU643216B2 (en) Production of IBDV VP2 in highly immunogenic form
US5403581A (en) Coccidiosis vaccines
US5597570A (en) Protein recognized by antibodies raised against native P28 of schistosoma mansoni
JP3215692B2 (ja) 組み換えコクシジウム症ワクチン
EP0614979B1 (fr) Vaccin et test de diagnostique pour le virus du choléra porcin
US5811103A (en) Hog cholera virus vaccine and diagnostic
EP0366684B1 (fr) Epitope vp2 de l'ibdv reconnu par des anticorps monoclonaux protecteurs et neutralisant ce virus
JP3135060B2 (ja) ヘモフィルスインフルエンザｂ型菌の外皮膜タンパク質Ｐ２の部分断片を用いた接合体
US5273744A (en) Vaccines for the protection of animals against theileria infection
CA2050275A1 (fr) Production de pvz du ibdv dans une forme hautement immunogene
AU618030B2 (en) Recombinant histidine-rich protein (37 kd antigen) of plasmodium falciparum, its preparation and use
WO1991000352A1 (fr) Sequences de nucleotides et polypeptides contre le pestivirus
AU619477B2 (en) Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies
WO1989006971A1 (fr) Segments de genes de rotavirus conserves et utilisation de tels segments dans des techniques d'immunisation et de neutralisation
CA1339265C (fr) Epitope ibdv vp2 reconnu par neutralisation et anticorps monoclonaux protecteurs
JPH11318475A (ja) マラリア特異性ｄｎａ配列物、それらの発現産物およびそれらの使用
JPH04505452A (ja) 高免疫原性形態のｉｂｄｖ　ｖｐ２の生産
Agron Foot-and-mouth-disease virus antigens-comprising peptides with amino acid sequence of viral protein antigenic sites

Legal Events

Date Code Title Description
FZDE Dead